Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Sara Horst

IBD · Vanderbilt

View

Dr. Laura Sahyoun

IBD · WCM

View

Dr. Uma Mahadevan

IBD · UCSF

View

Dr. Deborah Proctor

IBD · Yale College

View

Dr. Saurabh Sethi

General GI · Oja Health

View

Dr. Nneka Ufere

Liver Transplant · MGH

View

Dr. Wendi LeBrett

General GI · ModernGut

View

Dr. Treta Purohit

General GI · Oshi Health

View

Dr. Rushabh Modi

General GI · Kaiser Permanente

View

Dr. Brennan Spiegel

General GI · Cedars-Sinai

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    ELDr. Edward Loftus

    Dr. Edward Loftus

    Gastroenterology · Inflammatory Bowel Diseases
    Mayo Clinic
    edwardloftus

    Research

    Comparative risk of postoperative complications in ulcerative colitis patients following preoperative advanced therapies: a network meta-analysis with meta-regression

    2026

    Via J Crohns Colitis

    Oct 15, 2026Original Article

    Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis

    ​

    Written by 1 Roon author & 19 others

    Via The New England Journal of Medicine

    Research

    Benefit-Risk Profile of Upadacitinib: Exploratory Post Hoc Analysis of Phase 2b/3 Studies in Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

    2026

    Via Journal of Crohn's & Colitis

    Research

    Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease Across Nine Epidemiologic Stage 3 Regions

    2026

    Via Gastroenterology

    Research

    AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review

    2026

    Via Gastroenterology

    Research

    Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease

    2026

    Via Inflammatory Bowel Diseases

    Research

    IOIBD Evidence-Based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel Disease

    2026

    Via Journal of Crohn's & Colitis

    Research

    Impact of Mirikizumab on Patient-Reported Outcomes and Quality of Life in Patients With Crohn's Disease: Results From the Phase 2 SERENITY Study

    2026

    Via Crohn's & Colitis 360

    Research

    Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

    2026

    Via Gastro Hep Advances

    Research

    Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial

    2026

    Via Advances in Therapy

    Research

    Making Room Under the Umbrella for Microscopic Colitis

    2026

    Via The Lancet. Gastroenterology & Hepatology

    Research

    Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B SEQUENCE Study

    2026

    Via The American Journal of Gastroenterology

    Research

    Magnetic Resonance Imaging for Distinguishing Perianal Hidradenitis Suppurativa from Fistulizing Crohn Disease

    2025

    Via Dermatology (Basel)

    Research

    Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE Registry

    2025

    Via Crohn's & Colitis 360

    Research

    Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn's Disease

    2025

    Via Inflammatory Bowel Diseases